Cannabis
Hemp for Health Consolidates Its Share Capital
Vancouver, British Columbia–(Newsfile Corp. – November 29, 2021) – Further to its news release of November 17, 2021, HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the “Company”) announces that effective at the opening of trading on Thursday, December 2nd, 2021 (the “Effective Date”) the shares of the Company will commence trading on the Canadian Securities Exchange (the “Exchange”) on a consolidated basis, with one (1) new common share being issued for every two pre-consolidated shares (the “Consolidation”).
As a result of the Consolidation, on the Effective Date, a total of 12,081,500 common shares will be issued and outstanding, subject to adjustments for rounding, with 4,264,500 warrants outstanding. No fractional shares will be issued. The name of the Company has not been changed, and the trading symbol remains as “HFH”). A New CUSIP number has been issued, being 42371G206.
Following the Consolidation, the Company intends to complete its previously announced private placement raising up to $1.2 million through the issuance of up to 24,000,000 units (“Unit”) at a price of $0.05 per Unit (the “Financing”). Each Unit will consist of one post-consolidated share and one-half of one common share purchase warrant (“Warrant”), with each whole Warrant entitling the holder to purchase one post-consolidated share at $0.10 per share for a period of 24 months from closing. The Company will also be settling certain outstanding debt with various creditors in the aggregate amount of $400,125 through the issuance of up to 8,002,500 post-consolidated shares at a post-consolidated price of $0.05 per share (the “Debt Settlement”). (See news releases dated November 17 and 26, 2021.)
ON BEHALF OF HEMP FOR HEALTH INC.
(sgd.)” Robert Eadie
President & CEO
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
FOR FURTHER INFORMATION PLEASE CONTACT: Robert Eadie
Telephone: 604-602-4935
Toll Free: 1-866-602-4935
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/105299
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis6 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis5 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey